Bank of New York Mellon’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
43,954
+15,260
| +53% | +$447K | ﹤0.01% | 2970 |
|
|
2025
Q1 | $738K | Sell |
28,694
-520
| -2% | -$13.4K | ﹤0.01% | 3220 |
|
|
2024
Q4 | $843K | Sell |
29,214
-428
| -1% | -$12.4K | ﹤0.01% | 3237 |
|
|
2024
Q3 | $704K | Sell |
29,642
-10,095
| -25% | -$240K | ﹤0.01% | 3322 |
|
|
2024
Q2 | $687K | Buy |
39,737
+28,556
| +255% | +$494K | ﹤0.01% | 3383 |
|
|
2024
Q1 | $250K | Buy |
11,181
+316
| +3% | +$7.06K | ﹤0.01% | 3852 |
|
|
2023
Q4 | $199K | Sell |
10,865
-442
| -4% | -$8.11K | ﹤0.01% | 3949 |
|
|
2023
Q3 | $196K | Buy |
11,307
+589
| +5% | +$10.2K | ﹤0.01% | 3957 |
|
|
2023
Q2 | $195K | Buy |
+10,718
| New | +$195K | ﹤0.01% | 3974 |
|
|
2022
Q2 | – | Sell |
-10,943
| Closed | -$391K | – | 4710 |
|
|
2022
Q1 | $391K | Buy |
10,943
+4,403
| +67% | +$157K | ﹤0.01% | 3854 |
|
|
2021
Q4 | $569K | Buy |
6,540
+912
| +16% | +$79.3K | ﹤0.01% | 3722 |
|
|
2021
Q3 | $646K | Buy |
+5,628
| New | +$646K | ﹤0.01% | 3654 |
|